CATALOGO DEI PRODOTTI DELLA RICERCA

COLIZZI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.253
EU - Europa 2.577
AS - Asia 2.335
SA - Sud America 386
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 50
OC - Oceania 14
Totale 8.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.150
RU - Federazione Russa 1.089
SG - Singapore 837
CN - Cina 698
IT - Italia 523
BR - Brasile 285
VN - Vietnam 258
GB - Regno Unito 209
FR - Francia 207
HK - Hong Kong 201
IE - Irlanda 164
SE - Svezia 148
DE - Germania 95
KR - Corea 73
BD - Bangladesh 65
CA - Canada 51
AR - Argentina 36
ID - Indonesia 34
IN - India 33
JP - Giappone 30
FI - Finlandia 29
MX - Messico 25
EC - Ecuador 23
TR - Turchia 21
UA - Ucraina 21
NL - Olanda 19
ZA - Sudafrica 19
PK - Pakistan 14
PL - Polonia 14
AU - Australia 13
ES - Italia 13
CO - Colombia 12
SA - Arabia Saudita 11
IQ - Iraq 10
VE - Venezuela 8
MA - Marocco 7
PH - Filippine 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IL - Israele 6
MY - Malesia 6
UZ - Uzbekistan 6
CH - Svizzera 5
GT - Guatemala 5
JM - Giamaica 5
KE - Kenya 5
AT - Austria 4
ET - Etiopia 4
HN - Honduras 4
UY - Uruguay 4
BE - Belgio 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SD - Sudan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
EE - Estonia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LY - Libia 1
MT - Malta 1
NG - Nigeria 1
Totale 8.612
Salva come PNG Salva come JPEG
Città #
Ashburn 509
Singapore 402
San Jose 375
Chandler 297
Moscow 296
Dallas 207
Hong Kong 198
Council Bluffs 182
Dublin 159
Southend 142
Beijing 137
Verona 111
The Dalles 89
Ho Chi Minh City 86
Princeton 74
Lawrence 73
New York 68
Wilmington 67
Los Angeles 59
Jacksonville 55
Santa Clara 47
Hanoi 45
Nanjing 43
Redondo Beach 33
Milan 30
Buffalo 28
Dong Ket 28
Sindelfingen 26
São Paulo 26
Jinan 25
Rome 25
Shenyang 25
Tokyo 25
Hebei 24
Tianjin 23
Jakarta 21
Chicago 20
Denver 20
Guangzhou 20
Lappeenranta 17
Changsha 16
Guangdong 16
Ningbo 16
San Francisco 16
Bolzano 15
Montreal 15
Atlanta 14
Brooklyn 14
Nanchang 14
Seattle 14
Columbus 13
Haikou 13
Houston 13
Nuremberg 13
Phoenix 13
Redmond 13
Redwood City 13
Zhengzhou 13
Bologna 12
Johannesburg 12
Toronto 12
Amsterdam 11
Da Nang 11
Hangzhou 11
Orem 11
Warsaw 11
Helsinki 10
Kent 10
London 10
Norwalk 10
Ann Arbor 9
Charlotte 9
Mexico City 9
Poplar 9
Quito 9
Washington 9
Curitiba 8
Lanzhou 8
Marseille 8
Stockholm 8
Taizhou 8
Adrano 7
Ancona 7
Ankara 7
Boston 7
Brasília 7
Fairfield 7
Frankfurt am Main 7
Mumbai 7
Rio de Janeiro 7
Shanghai 7
Taiyuan 7
Boardman 6
Dearborn 6
Falls Church 6
Haiphong 6
Melbourne 6
Rio De Janeiro 6
Riyadh 6
Tashkent 6
Totale 4.741
Salva come PNG Salva come JPEG
Nome #
Lo stigma nella salute mentale 242
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 225
Postural control in childhood: investigating the neurodevelopmental gradient hypothesis 206
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the COVID-19 pandemic: an online student survey 190
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 187
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: an online parent survey 166
Cannabis use and the development of tolerance: a systematic review of human evidence 156
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: is there a role for motor abnormalities in atypical neurodevelopment? 154
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 153
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: a systematic review of human and animal evidence 153
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 151
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 149
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 148
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 145
Descriptive psychopathology of the acute effects of intravenous Delta-9-Tetrahydrocannabinol administration in humans 145
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 144
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 140
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 139
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study 138
Cannabis and cognition: connecting the dots towards the understanding of the relationship 138
Attachment styles in transsexual patients and clinical and nonclinical control groups: a response 136
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 133
Medically unexplained symptoms in the times of Covid-19 pandemic: a case-report 133
Cannabis: neuropsychiatry and its effects on brain and behavior 132
Additional evidence for neuropsychiatric manifestations in Mosaic Trisomy 20: a case report and brief review 132
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with Tourette syndrome: preliminary evidence from a case series 130
Dissociative symptoms in individuals with gender dysphoria: is the elevated prevalence real? 127
Differential gene expression analysis in blood of first episode psychosis patients 127
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 127
The relationship between dissociative experiences and cannabis use: a systematic review 126
Gender-oriented mental health prevention: a reappraisal 126
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 122
Cannabis and psychosis: what do we know and what should we do? 121
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 116
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 111
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 111
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 110
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 108
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 108
Is the adolescent brain at greater vulnerability to the effects of cannabis? A narrative review of the evidence 108
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 107
The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends 106
Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria 106
Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition 105
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 105
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study 103
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 101
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 101
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 100
To treat or not to treat: puberty suppression in childhood-onset gender dysphoria 98
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review 97
Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care? 97
Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style 95
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 92
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 90
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 89
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 87
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 87
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 86
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 85
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 84
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study 83
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 83
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 82
The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the monetary incentive delay task 80
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 79
Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior 78
Hyperprolactinaemia in first episode psychosis: a longitudinal assessment 78
Epigenetic mediation of AKT1 rs1130233's Effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 76
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 73
Substance use, medication adherence and outcome one year following a first episode of psychosis 72
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure 71
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 67
Editorial: The endocannabinoid system: filling the translational gap between neuroscience and psychiatry 65
Totale 8.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.571
article - articoli 33.273
book - libri 0
conference - conferenze 493
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 805
Totale 69.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022345 0 0 0 33 28 13 7 45 19 15 18 167
2022/2023930 87 81 103 129 115 211 5 53 107 10 21 8
2023/2024552 22 39 69 45 41 91 35 68 8 23 83 28
2024/20251.216 67 84 48 221 46 45 64 59 188 53 93 248
2025/20264.021 273 186 277 725 882 188 373 257 286 260 140 174
2026/2027726 182 88 132 324 0 0 0 0 0 0 0 0
Totale 8.721